US20050180970A1 - Binding domain-immunoglobulin fusion proteins - Google Patents

Binding domain-immunoglobulin fusion proteins Download PDF

Info

Publication number
US20050180970A1
US20050180970A1 US11/089,190 US8919005A US2005180970A1 US 20050180970 A1 US20050180970 A1 US 20050180970A1 US 8919005 A US8919005 A US 8919005A US 2005180970 A1 US2005180970 A1 US 2005180970A1
Authority
US
United States
Prior art keywords
method
hinge
constant region
hinge peptide
altered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/089,190
Inventor
Jeffrey Ledbetter
Martha Hayden-Ledbetter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Trubion Pharmaceuticals Inc
Original Assignee
Trubion Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US36735801P priority Critical
Priority to US10/053,530 priority patent/US20030133939A1/en
Application filed by Trubion Pharmaceuticals Inc filed Critical Trubion Pharmaceuticals Inc
Priority to US11/089,190 priority patent/US20050180970A1/en
Publication of US20050180970A1 publication Critical patent/US20050180970A1/en
Assigned to TRUBION PHARMACEUTICALS, INC. reassignment TRUBION PHARMACEUTICALS, INC. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: GENECRAFT, INC.
Application status is Abandoned legal-status Critical

Links